Belle.ai Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
41
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Belle.ai General Information
Description
Developer of an AI-powered skincare platform designed for precise epidemiology risk assessment. The company's platform identifies more than one thousand skin conditions and variations, including skin cancer, and measures the severity of autoimmune and inflammatory conditions such as acne, psoriasis, eczema, vitiligo, and alopecia areata, enabling healthcare professionals to address the unmet demands for global skin healthcare.
Contact Information
Website
www.belle.aiCorporate Office
- 245 First Street, Riverview II
- 18th Floor
- Cambridge, MA 02142
- United States
Corporate Office
- 245 First Street, Riverview II
- 18th Floor
- Cambridge, MA 02142
- United States
Belle.ai Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 24-Feb-2022 | Completed | Startup |
Belle.ai Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Belle.ai Patents
Belle.ai Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260311873-A1 | Compute system with image diagnostic mechanism and method of operation thereof | Pending | 07-Apr-2025 | ||
| US-12437403-B1 | Compute system with image diagnostic mechanism and method of operation thereof | Active | 28-Feb-2025 | ||
| US-12518385-B1 | Compute system with nail ailment diagnostic mechanism and method of operation thereof | Active | 27-Feb-2025 | ||
| US-12784213-B2 | Compute system with skin pathology mechanism and method of operation thereof | Active | 31-Jan-2025 | ||
| US-20260228884-A1 | Compute system with skin pathology mechanism and method of operation thereof | Active | 31-Jan-2025 | G06T7/0012 |
Belle.ai Signals
Belle.ai Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Lifeforce Capital | Venture Capital | Minority |
Belle.ai FAQs
-
When was Belle.ai founded?
Belle.ai was founded in 2021.
-
Where is Belle.ai headquartered?
Belle.ai is headquartered in Cambridge, MA.
-
What is the size of Belle.ai?
Belle.ai has 41 total employees.
-
What industry is Belle.ai in?
Belle.ai’s primary industry is Decision/Risk Analysis.
-
Is Belle.ai a private or public company?
Belle.ai is a Private company.
-
What is Belle.ai’s current revenue?
The current revenue for Belle.ai is .
-
How much funding has Belle.ai raised over time?
Belle.ai has raised $7.5M.
-
Who are Belle.ai’s investors?
Lifeforce Capital has invested in Belle.ai.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process